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Recently, the global trend in the field of nanomedicine has been toward the 
design of highly sophisticated drug delivery systems with active targeting and 
therapeutic functions, as well as responsiveness to biological stimuli for improving 
therapeutic efficacy. But offering sophistication generally increases their complexity 
that might be disadvantageous in pharmaceutical development. We hypothesize that 
using clinical anticancer drugs methotrexate (MTX) as both a targeting ligand and a 
therapeutic agent to interact with natural product phospholipid (PC) and thus 
self-assembly will lead to an efficient but simple and flexible, and multifunctional 
system. The main work is as follows: 
(1) MTX-PC complex was prepared by co-sovlent method and the reactive 
conditions such as reaction tempreture, reaction time and ratios of MTX and PC etc 
were optimized. Then, differential scanning calorimetry (DSC), Fourier transform 
infrared spectroscopy (FT-IR), X-ray diffractometry (XRD), thermal gravity analysis 
(TGA), and etc. were used to investigate the distribution state of MTX in the 
pharmaceutical MTX-PC complex matrix. 
(2) The self-assembled MTX-PC NPs were self-assembled by the amphiphilic 
MTX-PC complex with a novel lipid-drug complex film dispersion technique. The 
size, shape, potential, stability, and drug-release property of the self-assembly of 
MTX-PC complex were evaluated by several experiments. Results indicates that 
MTX-PC NPs possess amphiphilic property, high drug-loading effciency and 
enhanced permeability. 
(3) In vitro cell study and in vivo antitumor efficacy study of MTX-PC NPs: 
investigate the targeting efficacy and therapeutic efficacy of MTX-PC NPs towards 
FA receptors over-expressed cells by cellular uptake experiment, flow cytometry 















antitumor effect in H22 bearing mice after i.v. with MTX-PC NPs by observing growth 
condition, tumor size and weight. 
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acid，是在 60 年前首次被 Seeger 等合成，从化学结构上可视作叶酸的蝶呤基中
的羟基被氨基取代后的的叶酸衍生物[7]，橙黄色结晶性粉末，几乎不溶于水、乙
醇、三氯甲烷、二氯甲烷或乙醚，在 20°C 下 MTX 的水溶解度为 0.01 mg/mL。
MTX 在强酸性溶液中不稳定，酰胺基会水解，生成谷氨酸和蝶呤酸而失去活性。





图 1.1 甲氨蝶呤的化学结构式 
Fig. 1.1 The chemical structure of Methotrexate 
 
MTX 是一种抗叶酸类抗肿瘤药物，与二氢叶酸还原酶（DHFR）的结合比

















受到抑制[8]。此外，MTX 也有对胸腺核苷酸合成酶的抑制作用，但抑制 RNA 与
蛋白质合成的作用则较弱，主要作用于细胞周期的 S 期，属细胞周期特异性药物，





MTX 进入细胞是通过以下两种不同的机制：依赖能量的 FA 受体介导的主
动靶向和结合还原性叶酸载体的主动运输。当甲氨蝶呤进入细胞后，会经过谷氨
酸侧链的聚合反应演变成二氢叶酸还原酶抑制剂[9]。药物动力学研究结果表明，




























Fig. 1.2 Comparison of published researches and developments of methotrexate 
for treatment of cancer and rheumatoid arthritis according to involvement of 





少非特异性靶向增强抗肿瘤活性。Kong 等人报道了以 PAMAM、PEG 和 MTX
制备 PAMAM-PEG/MTX 复合物，结果显示复合物相比于纯药在肿瘤小鼠体内表
现出更长的血浆半衰期和作用时间，更好的抗肿瘤活性[13]。此外， Zhang 等人
成功地以 Generation 3 PAMAM 为药物载体，首先在 G3 PAMAM 表面引入水溶
性基团，然后将其与 MTX 多价共轭结合，构建了 PAMAM-MTX 配合物药物传
递系统[14]。在低 pH 的肿瘤环境下，树枝状大分子表面发生质子化，引起树枝状
大分子与 MTX 的排斥力作用，从而释放 MTX。实验结果显示该系统对于过度



















感染的效果，分别用空白脂质体、MTX 纯药、MTX 脂质体对大鼠连续 7 日进行
静脉注射，结果表明 MTX 脂质体有显著增强的抗炎作用[16]。在另一项研究中，
作者又指出，多室甲氨蝶呤脂质体（multilamellar vasicles conjugated MTX，
MTX-MLV）相对于纯药和普通 MTX 脂质体在静脉注射中都具有更强的抗炎效
果[17]。Prabhu 等人通过薄膜水合法后包裹一层亲水生物相容性聚合物如壳聚糖






等人制备了 MTX 与不同分子量的 PEG 连接的酯 MTX-PEGs，并表征了其理化
性能，所制备的 MTX-PEGs 中 MTX 与 PEGs 等摩尔比[19]。Shukla 等人使用相似
的方法也合成了 MTX-PEG 配合物并使用 99mTc 作标记[20]，药代动力学实验表
明了 MTX 的消除呈现为二室模型；使用 U87MG 人胶质瘤细胞做体外细胞毒性




载体。Kohler 等人成功制备了磁性 MTX 配合物纳米粒[21]，该磁性纳米粒首先被
三甲氧基硅烷修饰而构成自组装单层结构，然后与 MTX 通过酰胺键连接（MTX
的末端羧基与纳米粒表面的胺基连接），结果表明 MTX 在模拟溶酶体环境的低























制 Lewis 肺癌小鼠中肿瘤的发展[23]。Samor 等人用多种连接分子如多肽和酯将
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